Trial Profile
A Phase 3, Open-Label, 4 × 4 Crossover Study to Evaluate the Pharmacokinetic Drug-Drug Interaction of the Triple Therapy with TAK-438, Amoxicillin and Clarithromycin, or with TAK-438, Amoxicillin and Metronidazole in Healthy Japanese Male Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 01 Aug 2022
Price :
$35
*
At a glance
- Drugs Vonoprazan (Primary) ; Amoxicillin; Clarithromycin; Metronidazole
- Indications Duodenal ulcer; Erosive oesophagitis; Gastric ulcer; Gastro-oesophageal reflux; Helicobacter infections; Peptic ulcer; Reflux oesophagitis
- Focus Pharmacokinetics
- Sponsors Takeda Pharma
- 18 Jul 2016 Results published in the Advances in Therapy
- 16 Jun 2016 New trial record